How to Discuss HRT Risks With Your Clinician
A conversation about HRT should not leave you with a leaflet of frightening possibilities or the sense that you must simply accept what you are offered. The most useful way to discuss HRT risks is to put them in the context of your age, symptoms, medical history, treatment goals and the type of HRT being considered. For many women, the question is not whether HRT has any risks - all effective medicines can - but what those risks mean for them personally, and how they compare with the impact of untreated symptoms.
Start with the symptoms that are affecting your life
Begin by explaining what has changed and what you need help with. Hot flushes and night sweats are well recognised, but poor sleep, low mood, anxiety, brain fog, joint aches, palpitations, vaginal dryness, recurrent urinary symptoms and reduced sexual desire can also have a considerable effect on quality of life.
Be specific where you can. Say how often symptoms occur, how severe they are, whether they are affecting work, relationships or exercise, and what you have already tried. If you are still having periods, note any changes in timing, flow or pain. This helps your clinician assess whether symptoms are likely to be related to perimenopause or menopause, and whether there are other causes that need investigation.
It also establishes the potential benefit side of the discussion. Risk is not assessed in a vacuum. A treatment that offers little symptom relief may not be worthwhile for you; one that restores sleep, function and wellbeing may have a very different balance of benefits and risks.
How to discuss HRT risks in personal terms
Ask your clinician to explain absolute risk, not just relative risk. Relative figures can sound alarming without context. For example, a study may report a percentage increase in a risk, but the number of additional cases in a particular age group may still be small. A good consultation translates population research into a decision that makes sense for you.
You might ask: “What is my baseline risk without HRT?”, “How much would this particular treatment change it?”, and “What can we do to reduce that risk?” It is also reasonable to ask what would happen if you chose not to use HRT, or if you tried it for a defined period and reviewed the result.
The answer may depend on your age and stage of menopause. For most healthy women who begin HRT before age 60 or within 10 years of menopause, the balance of benefits and risks is often favourable when treatment is appropriately prescribed and reviewed. That does not mean one recommendation suits everyone. Earlier menopause, premature ovarian insufficiency, persistent bleeding, migraines, high blood pressure, metabolic health, family history and previous illness can all affect the plan.
Bring the information that changes the decision
A specialist will take a detailed history, but preparing in advance can make the appointment more productive. Tell them about any personal history of breast, ovarian, womb or bowel cancer; blood clots in the leg or lung; stroke; heart disease; liver disease; unexplained vaginal bleeding; endometriosis; fibroids; migraines; or gallbladder problems.
Family history matters too, particularly when a close relative developed breast or ovarian cancer at a young age, or when several relatives have had related cancers. However, family history does not automatically mean HRT is unsuitable. The pattern of cancer, whether genetic testing has been undertaken, your own health and the formulation under consideration all matter.
Bring a full list of medicines, supplements and previous hormone treatments, including contraception. Mention smoking or vaping, alcohol intake, blood pressure, diabetes, body weight and recent periods of reduced mobility, surgery or long-distance travel. These details are not a judgement. They help identify practical ways to prescribe more safely.
Ask which type of HRT is being recommended and why
“HRT” is a broad term, not one single medicine. The route, dose and hormones used can alter both effectiveness and risk.
If you have a uterus, systemic oestrogen is usually prescribed with a progestogen to protect the womb lining. Oestrogen taken without adequate progestogen can increase the risk of endometrial cancer. The type and regimen of progestogen should be part of the conversation, particularly if you have troublesome bleeding, mood sensitivity, endometriosis or breast cancer risk factors.
Oestrogen can be delivered through skin patches, gels or sprays, or as tablets. Transdermal oestrogen, absorbed through the skin, does not appear to carry the same increase in blood-clot risk as oral oestrogen and is often preferred for women with risk factors for venous thromboembolism, migraine, raised triglycerides or certain cardiovascular concerns. This is one reason a prescription should be tailored rather than selected from a standard menu.
Vaginal oestrogen is different again. It is a low-dose local treatment for vaginal and urinary symptoms, with minimal absorption into the bloodstream. It can often be used long term and may be suitable even where systemic HRT is not, though individual advice remains essential.
Discuss the risks honestly, without losing perspective
Breast cancer is understandably one of the most common concerns. The relationship between HRT and breast cancer varies according to the type of HRT used, duration of use, age and individual background risk. Combined HRT containing oestrogen and a progestogen is associated with a small increase in breast cancer risk that becomes more relevant with longer use. Oestrogen-only HRT has a different risk profile and is generally used after hysterectomy.
Your clinician should explain what this means in numbers relevant to your age, alongside the value of breast awareness and attending NHS breast screening when invited. Do not stop or avoid a potentially helpful treatment based on a headline alone, but do ensure the conversation includes your personal and family history.
Blood clots and stroke also need context. Oral oestrogen can increase clot risk, while transdermal oestrogen is usually the safer option for women at higher risk. Stroke risk rises with age regardless of HRT, and a clinician may consider your blood pressure, smoking status, migraine history and cardiovascular health when recommending the most appropriate route.
HRT is not generally prescribed to prevent heart disease. Yet for women who start treatment around menopause, there is no evidence that appropriately prescribed HRT increases coronary heart disease risk. Starting HRT much later requires more careful individual assessment. This is a good example of why a friend’s experience, or a general social-media claim, cannot replace personalised advice.
Make monitoring part of the plan
A prescription is the beginning of the process, not the end. Before you start, agree what success would look like: fewer night sweats, better sleep, improved mood, less pain during sex or a clearer sense of daily functioning. Discuss when your review will take place and what side effects or symptoms should prompt earlier contact.
Some adjustment is common during the first few months. Breast tenderness, nausea, headaches, bloating, skin irritation from patches or changes in bleeding can occur while your body adapts. These effects do not always mean HRT is wrong for you; a dose change, different route or alternative progestogen may help.
However, new heavy bleeding, bleeding after sex, bleeding that persists beyond the expected settling period, chest pain, sudden breathlessness, coughing blood, or a painful swollen leg need prompt medical assessment. Continuing to review treatment also allows your clinician to consider whether other support - such as nutrition, sleep strategies, mental health care, pelvic health input or treatment for sexual symptoms - would improve your overall outcome.
Give yourself permission to ask for a second conversation
You do not need to make a decision in one appointment. Ask for written information, take time to consider the options and return with questions. Equally, if you feel your concerns have been dismissed or your history has not been fully explored, seeking specialist menopause advice can be appropriate.
The right HRT plan is not necessarily the highest dose, the newest product or the treatment someone else recommends. It is a carefully considered option that reflects your symptoms, medical background, preferences and willingness to review treatment over time.
A calm, informed conversation can replace uncertainty with a plan you understand and can feel confident about. If you would like individualised, evidence-based advice, book an appointment through our consultations page to discuss your symptoms, treatment options and personal HRT risk profile.
